{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:42:39Z","timestamp":1793875359140,"version":"4.6.1"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"\n Importance<\/jats:title>\n Major depressive disorder (MDD) and obesity are common noncommunicable disorders associated with substantial disease burden, which frequently occur comorbidly. Intriguingly, converging lines of evidence from animal models and genetic and observational studies have suggested a biological link between obesity, metabolic syndrome, and depression. Several small randomized clinical trials (RCTs) have suggested the antidepressive potential of statins.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine whether simvastatin added to escitalopram is efficacious in improving depressive symptoms compared with add-on placebo.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a confirmatory, double-blind, placebo-controlled, multicenter RCT. Adults with MDD and comorbid obesity from 9 tertiary care settings in Germany were enrolled in this analysis. Data were analyzed from July to October 2024.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Simvastatin (40 mg per day) or placebo as add-on to escitalopram (10 mg for the first 2 weeks, then increased to 20 mg until the end of study) in a double-blind fashion for 12 weeks.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was change in Montgomery-\u00c5sberg Depression Rating Scale (MADRS) score from baseline (week 0) to week 12.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n From August 21, 2020, to June 06, 2024, a total of 161 patients were enrolled at 9 sites in Germany, of which 160 patients were included in the intention-to-treat analysis (placebo: n\u2009=\u200979, simvastatin: n\u2009=\u200981; mean [SD] age, 39.0 [11.0] years; 126 female [79%]). Retention in the trial was excellent (95.6%), and blinding was effectively maintained. There were 4 serious adverse events with no difference between the groups. Primary end point analysis in the intention-to-treat sample showed no significant treatment effect of add-on simvastatin in MADRS scores (mixed models for repeated measures least squares mean difference, 0.47 points; 95% CI, \u22122.08 to 3.02;\n P<\/jats:italic>\n \u2009=\u2009.71). No effects of simvastatin treatment were observed in any of the mental health\u2013related secondary end points. However, simvastatin treatment significantly reduced low-density lipoprotein cholesterol (simvastatin, \u221240.37 mg\/dL; 95% CI, \u221247.41 to \u221233.33 mg\/dL; placebo, \u22123.78 mg\/dL; 95% CI, \u221211.18 to 3.62 mg\/dL;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), total cholesterol (simvastatin, \u221239.07 mg\/dL; 95% CI, \u221249.42 to \u221228.73 mg\/dL; placebo, \u22124.89 mg\/dL; 95% CI, \u221215.64 to 5.87 mg\/dL;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and C-reactive protein (simvastatin, \u22121.04 mg\/L; 95% CI, \u22121.89 to \u22120.20 mg\/L; placebo, 0.57 mg\/L; 95% CI, \u22120.28 to 1.42 mg\/L;\n P<\/jats:italic>\n \u2009=\u2009.003) compared with placebo.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The study failed to meet its primary end point. This demonstrates that simvastatin did not exert additional antidepressive effects when added to escitalopram in patients with comorbid MDD and obesity, despite improving the cardiovascular risk profile.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04301271<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2025.0801","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:00:55Z","timestamp":1749034855000},"page":"759","source":"Crossref","is-referenced-by-count":13,"title":["Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity"],"prefix":"10.1001","volume":"82","author":[{"given":"Christian","family":"Otte","sequence":"first","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Center for Mental Health partner site Berlin\/Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Ri","family":"Chae","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Center for Mental Health partner site Berlin\/Potsdam, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz Yildirim","family":"Dogan","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Piber","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Roepke","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Bin","family":"Cho","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Berlin Institute of Health at Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Trumm","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kaczmarczyk","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Brasanac","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Wingenfeld","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Center for Mental Health partner site Berlin\/Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Koglin","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wieditz","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Junghanns","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, L\u00fcbeck University, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lucht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prvulovic","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Medical Centre Frankfurt, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tillmann H. C.","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hanover, Germany"},{"name":"Centre for Systems Neuroscience Hannover, Hanover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Terock","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Helios Hanseklinikum Stralsund, Stralsund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Haaf","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hofmann","sequence":"additional","affiliation":[{"name":"German Center for Mental Health partner site Berlin\/Potsdam, Germany"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Center for Patient-Centered Outcomes Research, Berlin, Germany"},{"name":"Department of Psychosomatic Medicine and Psychotherapy, DRK Kliniken Berlin Wiegmann Klinik, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mauche","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Philipp","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, L\u00fcbeck University, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00f6rgen","family":"Grabe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Medical Centre Frankfurt, Frankfurt am Main, Germany"},{"name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai G.","family":"Kahl","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hanover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Janowitz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Helios Hanseklinikum Stralsund, Stralsund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Leicht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Hinkelmann","sequence":"additional","affiliation":[{"name":"German Center for Mental Health partner site Berlin\/Potsdam, Germany"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Center for Patient-Centered Outcomes Research, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Strau\u00df","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Friede","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Gold","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychiatry and Psychotherapy, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"German Center for Mental Health partner site Berlin\/Potsdam, Germany"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"yoi250023r1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"10440","key":"yoi250023r2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"10328","key":"yoi250023r3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","article-title":"Time for united action on depression: a Lancet-World Psychiatric Association Commission.","volume":"399","author":"Herrman","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"yoi250023r5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","article-title":"Depression and obesity: evidence of shared biological mechanisms.","volume":"24","author":"Milaneschi","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"3","key":"yoi250023r6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi250023r7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41398-023-02533-z","article-title":"The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.","volume":"13","author":"De Giorgi","year":"2023","journal-title":"Transl Psychiatry"},{"key":"yoi250023r8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jad.2013.11.026","article-title":"Statins use and risk of depression: a systematic review and meta-analysis.","volume":"160","author":"Parsaik","year":"2014","journal-title":"J Affect Disord"},{"key":"yoi250023r9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jad.2020.12.164","article-title":"Statin use and depression risk: a systematic review and meta-analysis.","volume":"282","author":"Lee","year":"2021","journal-title":"J Affect Disord"},{"issue":"11","key":"yoi250023r10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S2215-0366(20)30311-4","article-title":"Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study.","volume":"7","author":"Molero","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"yoi250023r11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.genhosppsych.2024.07.015","article-title":"Association of statin use with risk of depression and anxiety: a prospective large cohort study.","volume":"90","author":"Yang","year":"2024","journal-title":"Gen Hosp Psychiatry"},{"key":"yoi250023r12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jad.2024.01.013","article-title":"The association between statin use and depression in diabetes.","volume":"349","author":"Li","year":"2024","journal-title":"J Affect Disord"},{"key":"yoi250023r13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2014.07.018","article-title":"In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder.","volume":"58","author":"Haghighi","year":"2014","journal-title":"J Psychiatr Res"},{"issue":"11","key":"yoi250023r14","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/da.22195","article-title":"Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.","volume":"30","author":"Ghanizadeh","year":"2013","journal-title":"Depress Anxiety"},{"issue":"5","key":"yoi250023r15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0269881115578160","article-title":"Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: a double-blind placebo-controlled trial.","volume":"29","author":"Gougol","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"4","key":"yoi250023r16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000521104","article-title":"Effect of low-dose statins in addition to standard therapy on brain perfusion and neurocognitive performance in patients with major depressive disorder.","volume":"81","author":"Massardo","year":"2022","journal-title":"Neuropsychobiology"},{"key":"yoi250023r17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1381523","article-title":"Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK\/NLRP3 inflammasome and IL-6\/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study.","volume":"15","author":"Aldossary","year":"2024","journal-title":"Front Pharmacol"},{"key":"yoi250023r18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jad.2016.04.047","article-title":"Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials.","volume":"200","author":"Salagre","year":"2016","journal-title":"J Affect Disord"},{"issue":"3","key":"yoi250023r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249409","article-title":"Statins for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.","volume":"16","author":"De Giorgi","year":"2021","journal-title":"PLoS One"},{"key":"yoi250023r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107625","article-title":"Statins in the treatment of depression: hype or hope?","volume":"215","author":"K\u00f6hler-Forsberg","year":"2020","journal-title":"Pharmacol Ther"},{"key":"yoi250023r21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression.","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi250023r22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040119","article-title":"Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicenter, randomized, double-blind, placebo-controlled trial.","volume":"10","author":"Otte","year":"2020","journal-title":"BMJ Open"},{"key":"yoi250023r23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jad.2021.03.032","article-title":"Is obesity a determinant of success with pharmacological treatment for depression: a systematic review, meta-analysis and meta-regression.","volume":"287","author":"Grigolon","year":"2021","journal-title":"J Affect Disord"},{"key":"yoi250023r24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"4","key":"yoi250023r26","first-page":"323","article-title":"Development, reliability, and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning.","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr Scand"},{"issue":"15","key":"yoi250023r27","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1017\/S0033291715001270","article-title":"Minimal clinically important difference on the Beck Depression Inventory II according to the patient\u2019s perspective.","volume":"45","author":"Button","year":"2015","journal-title":"Psychol Med"},{"issue":"10456","key":"yoi250023r28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","article-title":"Obesity in adults.","volume":"404","author":"Lingvay","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"yoi250023r29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41573-021-00368-1","article-title":"Immune targets for therapeutic development in depression: towards precision medicine.","volume":"21","author":"Drevets","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"yoi250023r30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41380-022-01887-y","article-title":"Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.","volume":"28","author":"Miller","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"1","key":"yoi250023r31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection.","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"yoi250023r32","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study.","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"yoi250023r33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12916-019-1475-6","article-title":"Youth Depression Alleviation With Antiinflammatory Agents (YoDA-A): a randomized clinical trial of rosuvastatin and aspirin.","volume":"18","author":"Berk","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"yoi250023r35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-020-0200-2","article-title":"Comorbid depression in medical diseases.","volume":"6","author":"Gold","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"yoi250023r36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/eurheartj\/ehad539","article-title":"Recommendations for statin management in primary prevention: disparities among international risk scores.","volume":"45","author":"Mancini","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"yoi250023r37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1192\/bjp.bp.111.094532","article-title":"Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis.","volume":"201","author":"Mitchell","year":"2012","journal-title":"Br J Psychiatry"},{"key":"yoi250023r25","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"yoi250023r34","volume-title":"Detection of Associations Between Trial Quality and Effect Sizes","author":"Hempel","year":"2012"},{"key":"yoi250023r4","unstructured":"World Health Organization. Obesity and overweight. Accessed June 10, 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2834608\/jamapsychiatry_otte_2025_oi_250023_1753816573.60228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:00:42Z","timestamp":1754492442000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2834608"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.0801","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}